Skip to main content

Articles

Page 88 of 107

  1. Overexpression of cyclooxygenase (COX-2) is commonly observed in human cancers. In a murine model of metastatic breast cancer, we observed that COX-2 expression and enzyme activity were associated with enhanced t...

    Authors: Xinrong Ma, Qingyuan Yang, Keith T Wilson, Namita Kundu, Stephen J Meltzer and Amy M Fulton
    Citation: Breast Cancer Research 2004 6:R316
  2. The S100A7 (psoriasin) gene is highly expressed in ductal carcinoma in situ (DCIS) of the breast and can be downregulated in invasive carcinoma. Persistent S100A7 expression in invasive carcinoma is associated wi...

    Authors: Ethan D Emberley, Salem Alowami, Linda Snell, Leigh C Murphy and Peter H Watson
    Citation: Breast Cancer Research 2004 6:R308
  3. Inflammatory breast cancer is a special type of locally advanced mammary cancer that is associated with particularly aggressive behaviour and poor prognosis. The dog was considered the only natural model in wh...

    Authors: M Dolores Pérez-Alenza, Ángeles Jiménez, Ana I Nieto and Laura Peña
    Citation: Breast Cancer Research 2004 6:R300
  4. A founder mutation in the BRCA2 gene (BRCA2 999del5) accounts for 7–8% of female breast cancers and for 40% of male breast cancers in Iceland. If expressed, the mutant gene would encode a protein consisting of th...

    Authors: Evgenia K Mikaelsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord and Thorunn Rafnar
    Citation: Breast Cancer Research 2004 6:R284
  5. The purpose of the present study was to determine whether cytotoxic chemotherapeutic agents administered prior to immunotherapy with gene vaccines could augment the efficacy of the vaccines.

    Authors: Yesim Eralp, Xiaoyan Wang, Jian-Ping Wang, Maureen F Maughan, John M Polo and Lawrence B Lachman
    Citation: Breast Cancer Research 2004 6:R275
  6. A polymorphism in the manganese superoxide dismutase (MnSOD) gene, Ala-9Val, has been examined in association with breast cancer risk in several epidemiologic studies. Results suggest that the Ala allele increase...

    Authors: Robert C Millikan, Jon Player, Allan René de Cotret, Patricia Moorman, Gary Pittman, Vani Vannappagari, Chiu-Kit J Tse and Temitope Keku
    Citation: Breast Cancer Research 2004 6:R264
  7. There is evidence that diets which contain high levels of phytoestrogenic isoflavanoids are associated with a low incidence of osteoporosis and menopausal vasomotor symptoms. Plant extracts such as red clover,...

    Authors: Trevor Powles
    Citation: Breast Cancer Research 2004 6:140
  8. The overexpression of the ErbB family of tyrosine kinase receptors is thought to be important in the development of many breast tumours. To date, most attention has focused on the ErbB2 receptor. Now, in a rec...

    Authors: Elena Perez-Nadales and Alison C Lloyd
    Citation: Breast Cancer Research 2004 6:137
  9. Little is known of the function and clinical significance of intratumoral dysregulation of xenobiotic-metabolizing enzyme expression in breast cancer. One molecular mechanism proposed to explain tamoxifen resi...

    Authors: Ivan Bièche, Igor Girault, Estelle Urbain, Sengül Tozlu and Rosette Lidereau
    Citation: Breast Cancer Research 2004 6:R252
  10. Although the effects of progesterone on cell cycle progression are well known, its role in spreading and adhesion of breast cancer cells has not attracted much attention until recently. Indeed, by controlling ...

    Authors: Haiyan Pang, Brian G Rowan, Mariam Al-Dhaheri and Lee E Faber
    Citation: Breast Cancer Research 2004 6:R239
  11. Phytoestrogens are polyphenol compounds of plant origin that exhibit a structural similarity to the mammalian steroid hormone 17β-oestradiol. In Asian nations the staple consumption of phyto-oestrogen-rich foo...

    Authors: Jane L Limer and Valerie Speirs
    Citation: Breast Cancer Research 2004 6:119
  12. Transforming growth factor (TGF)-β1 is proposed to inhibit the growth of epithelial cells in early tumorigenesis, and to promote tumor cell motility and invasion in the later stages of carcinogenesis through t...

    Authors: Kimberly A Brown, Mary E Aakre, Agnieska E Gorska, James O Price, Sakina E Eltom, Jennifer A Pietenpol and Harold L Moses
    Citation: Breast Cancer Research 2004 6:R215
  13. The aim of the present article is to investigate effects of hormone replacement therapy (HRT) on contrast medium enhancement patterns in postmenopausal patients during magnetic resonance mammography (MRM).

    Authors: Stefan OR Pfleiderer, Steffen Sachse, Dieter Sauner, Christiane Marx, Ansgar Malich, Susanne Wurdinger and Werner A Kaiser
    Citation: Breast Cancer Research 2004 6:R232
  14. A multitude of molecules involved in breast cancer biology have been studied as potential prognostic markers. In the present review we discuss the role of established molecular markers, as well as potential ap...

    Authors: Francisco J Esteva and Gabriel N Hortobagyi
    Citation: Breast Cancer Research 2004 6:109
  15. Deficiencies in cellular responses to DNA damage can predispose to cancer. Ionizing radiation can cause cluster damage and double-strand breaks (DSBs) that pose problems for cellular repair processes. Three ge...

    Authors: Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver, Roy E Shore, John D Boice Jr, Gertrud S Berkowitz, Richard A Gatti, Susan L Teitelbaum, Susan A Smith…
    Citation: Breast Cancer Research 2004 6:R199
  16. Hypoxia-inducible factor 1 alpha (hif-1α) furnishes tumor cells with the means of adapting to stress parameters like tumor hypoxia and promotes critical steps in tumor progression and aggressiveness. We invest...

    Authors: Günther Gruber, Richard H Greiner, Ruslan Hlushchuk, Daniel M Aebersold, Hans J Altermatt, Gilles Berclaz and Valentin Djonov
    Citation: Breast Cancer Research 2004 6:R191
  17. The CCCTC-binding factor (CTCF), known as a versatile transcription factor and chromatin insulator and to be involved in X inactivation, has also been suggested to be a tumour suppressor on 16q. We investigate...

    Authors: Xiao-Lei Zhou, Barbro Werelius and Annika Lindblom
    Citation: Breast Cancer Research 2004 6:R187
  18. We have shown previously that whilst overexpression of HER1, 2 and 3 is associated with poor prognosis in breast cancer, HER4 is associated with a good prognosis. Cell proliferation is a key component of aggre...

    Authors: Sian M Tovey, Caroline J Witton, John MS Bartlett, Peter D Stanton, Jonathan R Reeves and Timothy G Cooke
    Citation: Breast Cancer Research 2004 6:R246
  19. Receptor-mediated estrogen activation participates in the development and progression of breast cancer. Estrogen receptor (ER)-α polymorphism has been found to be associated with breast cancer and clinical fea...

    Authors: Wei-Chiang Hsiao, Kung-Chia Young, Shoei-Loong Lin and Pin-Wen Lin
    Citation: Breast Cancer Research 2004 6:R180
  20. In order to study metastatic disease, we employed the use of two related polyomavirus middle T transgenic mouse tumor transplant models of mammary carcinoma (termed Met and Db) that display significant differe...

    Authors: Katayoun Alavi Jessen, Stephenie Y Liu, Clifford G Tepper, Juliana Karrim, Erik T McGoldrick, Andrea Rosner, Robert J Munn, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff and Jeffrey P Gregg
    Citation: Breast Cancer Research 2004 6:R157
  21. Isoflavones are hypothesized to protect against breast cancer, but it is not clear whether they act as oestrogens or anti-oestrogens in breast tissue. Our aim was to determine the effects of taking a red clove...

    Authors: Charlotte Atkinson, Ruth ML Warren, Evis Sala, Mitch Dowsett, Alison M Dunning, Catherine S Healey, Shirley Runswick, Nicholas E Day and Sheila A Bingham
    Citation: Breast Cancer Research 2004 6:R170
  22. Invasive lobular carcinoma (ILC) comprises approximately 10% of breast cancers and appears to have a distinct biology. Because it is less common than infiltrating ductal carcinoma (IDC), few data have been rep...

    Authors: Grazia Arpino, Valerie J Bardou, Gary M Clark and Richard M Elledge
    Citation: Breast Cancer Research 2004 6:R149
  23. So far there have been no reports on the expression pattern of DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1) in human breast cells and its relationship to the ...

    Authors: Isabel Conde, Juan M Alfaro, Benito Fraile, Antonio Ruíz, Ricardo Paniagua and Maria I Arenas
    Citation: Breast Cancer Research 2004 6:R140
  24. Early-stage cancers have long been considered to be less aggressive than late-stage cancers because it is assumed that they have accumulated fewer of the mutations that are required for full metastatic potenti...

    Authors: Pepper Schedin and Anthony Elias
    Citation: Breast Cancer Research 2004 6:93
  25. The developmental preparation of the mammary gland for milk production that occurs during pregnancy is followed by an equally dramatic process of involution as the gland returns to its prepregnancy state. Two ...

    Authors: Stephen R Master and Lewis A Chodosh
    Citation: Breast Cancer Research 2004 6:89
  26. The transforming growth factor-β (TGF-β) signaling pathway functions to prevent tumorigenesis, and loss of sensitivity to TGF-β-mediated cell cycle arrest is nearly ubiquitous among human cancers. Our previous...

    Authors: Kimberly A Brown, Richard L Roberts, Carlos L Arteaga and Brian K Law
    Citation: Breast Cancer Research 2004 6:R130
  27. The San Antonio Breast Cancer Symposium is the largest annual meeting devoted solely to breast cancer research. The late William L McGuire's vision for this meeting was to stimulate 'translational research', m...

    Authors: Adrian V Lee, Gary Chamness and Steffi Oesterreich
    Citation: Breast Cancer Research 2004 6:E10
  28. The normal duct and lobular system of the mammary gland is lined with luminal and myoepithelial cell types. Although evidence suggests that myoepithelial cells might suppress tumor growth, invasion and angioge...

    Authors: Viviana Bumaschny, Alejandro Urtreger, Miriam Diament, Martín Krasnapolski, Gabriel Fiszman, Slobodanka Klein and Elisa Bal de Kier Joffé
    Citation: Breast Cancer Research 2004 6:R116
  29. Inflammatory breast cancer (IBC) is the most lethal form of locally advanced breast cancer. We found concordant and consistent alterations of two genes in 90% of IBC tumors when compared with stage-matched non...

    Authors: Celina G Kleer, Yanhong Zhang, Quintin Pan, Gary Gallagher, Mei Wu, Zhi-Fen Wu and Sofia D Merajver
    Citation: Breast Cancer Research 2003 6:R110
  30. In order to gain a better understanding of the molecular processes that underlie apoptosis and tissue regression in mammary gland, we undertook a large-scale analysis of transcriptional changes during the mous...

    Authors: Richard WE Clarkson, Matthew T Wayland, Jennifer Lee, Tom Freeman and Christine J Watson
    Citation: Breast Cancer Research 2003 6:R92
  31. Involution of the mammary gland is a complex process of controlled apoptosis and tissue remodelling. The aim of the project was to identify genes that are specifically involved in this process.

    Authors: Torsten Stein, Joanna S Morris, Claire R Davies, Stephen J Weber-Hall, Marie-Anne Duffy, Victoria J Heath, Alexandra K Bell, Roderick K Ferrier, Gavin P Sandilands and Barry A Gusterson
    Citation: Breast Cancer Research 2003 6:R75
  32. This American Association for Cancer Research Special Conference brought together scientists with diverse expertise to address issues related to use of appropriate epidemiological, statistical, and laboratory ...

    Authors: David G Cox
    Citation: Breast Cancer Research 2003 6:E9
  33. The oncoprotective role of food-derived polyphenol antioxidants has been described but the implicated mechanisms are not yet clear. In addition to polyphenols, phenolic acids, found at high concentrations in a...

    Authors: Marilena Kampa, Vassilia-Ismini Alexaki, George Notas, Artemissia-Phoebe Nifli, Anastassia Nistikaki, Anastassia Hatzoglou, Efstathia Bakogeorgou, Elena Kouimtzoglou, George Blekas, Dimitrios Boskou, Achille Gravanis and Elias Castanas
    Citation: Breast Cancer Research 2003 6:R63
  34. The aim of the present study was to identify the relationships between the uptake of radiotracers – namely pentavalent dimercaptosuccinic acid [(V)DMSA] and sestamibi (MIBI) – and the following parameters in p...

    Authors: Vassilios J Papantoniou, Michael A Souvatzoglou, Varvara J Valotassiou, Androniki N Louvrou, Constantina Ambela, John Koutsikos, Dimitrios Lazaris, Julie K Christodoulidou, Maria G Sotiropoulou, Maria J Melissinou, Aris Perperoglou, Spyridon Tsiouris and Cherry J Zerva
    Citation: Breast Cancer Research 2003 6:R56
  35. The expression of the oestrogen receptor (ER) is one of the more important clinical parameters of breast cancer. However, the relationship between the ER and its ligand, oestradiol, and the enzymes that synthe...

    Authors: Noriko Yoshimura, Nobuhiro Harada, Ida Bukholm, Rolf Kåresen, Anne-Lise Børresen-Dale and Vessela N Kristensen
    Citation: Breast Cancer Research 2003 6:R46
  36. The aim of the present study was to analyze the relationship between the expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in breast cancer cells and the corresp...

    Authors: Anna Maria Granato, Oriana Nanni, Fabio Falcini, Secondo Folli, Gabriella Mosconi, Franca De Paola, Laura Medri, Dino Amadori and Annalisa Volpi
    Citation: Breast Cancer Research 2003 6:R38
  37. The recent meeting 'Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications' was an American Association for Cancer Research (AACR) Special Conference in Cancer Research, for which th...

    Authors: Alana L Welm
    Citation: Breast Cancer Research 2003 6:E6

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions